Redline Networks, a company that designs and manufactures network appliances that maximise the performance, flexibility, and scalability of Web-enabled applications, today announced that Serono, the world's third-largest biotechnology firm, has selected Redline Networks' E|X application processors to boost the performance of several business critical Web-based applications. Serono will deploy the Redline application processors across its worldwide enterprise network on Web-based applications including Lotus Domino Web Access, IBM's WebSphere, Siebel and multiple Web enabled application servers.
The Geneva, Switzerland-based company started deploying the Redline products in early 2004 as part of a world-wide initiative to further Web-enable Serono's enterprise applications. By Web-enabling the applications, Serono can convert the applications to HTTP, the core language of the Internet. This allows the applications to be centrally administered and maintained and allows the company's 5,000 employees to access the applications through Web browsers. Serono has initially deployed Redline appliances in consolidated data centers in Geneva and in the Serono's U.S. data centre in Rockland, Mass.
"More than a quarter of our employees are permanently remote with dial-up access, or are mobile workers using hotel or kiosk connections to access their e-mail for example," said Rael Paster, head of collaboration services at Serono. "These users would have had to pull down three megabytes of data just to log in and read their in-box. HTTP can be very hard on servers and we needed to compress the data. Compression alone was not going to be enough, we wanted a solution that would also do load balancing and offload processing from our servers, so we could achieve higher performance from our existing servers."
Serono evaluated the Redline equipment both by conducting thorough internal testing and by commissioning an outside test through Swiss quality-of-service vendor eb-Qual. The eb-Qual test determined that deploying a Redline enterprise application processor in Domino Web Access server environment boosted server capacity by more than 500 percent, thus requiring fewer servers. In addition, page-download times were reduced by up to 70 percent.
"The Redline product not only performed as advertised but actually exceeded our expectations," added Paster. "Members of our user test group, who previously had called the system 'unusable,' were thrilled when they saw average response times improve by 93 percent after the Redline box was installed. Now that the Redline is in our production environment, we expect it to considerably reduce our communication costs and increase user satisfaction. Originally, we just wanted the Redline unit to offload as much processing as possible from the servers. Instead, we received several products in one. This one appliance compresses the data, multiplexes the sessions to the servers, load balances, performs layer 7 health checks and eliminates SSL key negotiations."
Serono is also using Redline's OverDrive control environment, which allows enterprise data centres to tailor the behaviour of Web-enabled applications by writing simple rules for processing HTTP content. "We are decommissioning a legacy SSL VPN product that does not support compression," added Paster. "OverDrive has let us write simple rules that turn off compression when information is requested by the server associated with that SSL VPN."
Serono utilises Redline's advanced security features to provide remote users high-speed access to the company's clinical product trials and other Web services eliminating the need for some virtual private networks (VPNs).
For complete results of the eb-Qual test, please visit:http://www.redlinenetworks.com/pdf/eb_qual_test_report.pdf or send a request to email@example.com.
Serono is a global biotechnology leader. The Company has eight biotechnology products, Rebif®, Gonal-F®, Luveris®, Ovidrel®/Ovitrelle®, Serostim®, Saizen®, Zorbtive™ and Raptiva®. In addition to being the world leader in reproductive health, Serono has strong market positions in neurology, metabolism and growth and has recently entered the psoriasis area. The Company's research programs are focused on growing these businesses and on establishing new therapeutic areas. Currently, there are approximately 30 ongoing development projects. In 2003, Serono achieved worldwide revenues of US$2,018.6 million, and a net income of US$390.0 million, making it the third largest biotech company in the world. Its products are sold in over 90 countries. Bearer shares of Serono S.A., the holding company, are traded on the virt-x (SEO) and its American Depositary Shares are traded on the New York Stock Exchange (SRA).
About Redline Networks
Redline Networks designs and manufactures network appliances that maximize the performance, flexibility, and scalability of Web-enabled enterprise data centers. The company's family of E|X enterprise application processors, deployed at corporate data centers, and T|X Web I/O processors, used by Web sites, enable users to control and customize any HTTP-based environment while reducing infrastructure cost and complexity. Redline is a privately-held company based in Campbell, Calif. For more information on Redline and its products, visit http://www.RedlineNetworks.com.
For more information:
Tel: +44 (0) 870 242 7458
Cell: +44 (0) 7974 398 414
This press release was distributed by ResponseSource Press Release Wire on behalf of Ascendant Communications in the following categories: Computing & Telecoms, for more information visit https://pressreleasewire.responsesource.com/about.